» Articles » PMID: 32521208

CEACAM1 Regulates CD8 T Cell Immunity and Protects from Severe Pathology During Induced Colitis

Overview
Journal Gut Microbes
Date 2020 Jun 11
PMID 32521208
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of gastrointestinal infections continues to increase, and infectious colitis contributes significantly to morbidity and mortality worldwide. Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) has been discovered to be strongly involved in the intestinal homeostasis. However, whether intestinal CEACAM1 expression has an impact on the control of infectious colitis remains elusive. is a gram-negative enteric pathogen that induces colonic inflammation in mice, with a critical role for CD4 T cell but not CD8 T cell immunity to primary infection. Here, we show that mice are much more susceptible to infection than wildtype mice, which is mediated by a defect in the intestinal barrier and, surprisingly, by a dysregulated CD8 T cell but not CD4 T cell response in the colon. CEACAM1 expression is essential for the control of CD8 T cell immunity, as CEACAM1 deficiency during infection inhibits CD8 T cell exhaustion. We conclude that CEACAM1 is an important regulator of CD8 T cell function in the colon, and blocking CEACAM1 signaling to activate CD8 T cells may have unforeseen side effects.

Citing Articles

Elucidating the role of S100A10 in CD8 T cell exhaustion and HCC immune escape via the cPLA2 and 5-LOX axis.

Wang G, Shen X, Jin W, Song C, Dong M, Zhou Z Cell Death Dis. 2024; 15(8):573.

PMID: 39117605 PMC: 11310305. DOI: 10.1038/s41419-024-06895-0.


Vitamin A deficiency suppresses CEACAM1 to impair colonic epithelial barrier function via downregulating microbial-derived short-chain fatty acids.

Yan J, Xiao L, Feng D, Chen B, Yang T, Tong B Genes Dis. 2023; 11(2):1066-1081.

PMID: 37692511 PMC: 10491915. DOI: 10.1016/j.gendis.2023.03.032.


CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens.

Thomas J, Klebanov A, John S, Miller L, Vegesna A, Amdur R Genes Cancer. 2023; 14:12-29.

PMID: 36741860 PMC: 9891707. DOI: 10.18632/genesandcancer.230.


Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.

He G, Chen Z, Zhuo S, Tang J, Hao W, Yang K Hum Cell. 2022; 35(6):1976-1992.

PMID: 36129672 DOI: 10.1007/s13577-022-00791-5.


Tumorigenic bacteria in colorectal cancer: mechanisms and treatments.

Li S, Liu J, Zheng X, Ren L, Yang Y, Li W Cancer Biol Med. 2021; .

PMID: 34586760 PMC: 8832957. DOI: 10.20892/j.issn.2095-3941.2020.0651.


References
1.
Tindemans I, Joosse M, Samsom J . Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD. Cells. 2020; 9(1). PMC: 7016883. DOI: 10.3390/cells9010110. View

2.
Gray-Owen S, Blumberg R . CEACAM1: contact-dependent control of immunity. Nat Rev Immunol. 2006; 6(6):433-46. DOI: 10.1038/nri1864. View

3.
Pearson J, Giogha C, Ong S, Kennedy C, Kelly M, Robinson K . A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature. 2013; 501(7466):247-51. PMC: 3836246. DOI: 10.1038/nature12524. View

4.
Moller M, Kammerer R, Grunert F, von Kleist S . Biliary glycoprotein (BGP) expression on T cells and on a natural-killer-cell sub-population. Int J Cancer. 1996; 65(6):740-5. DOI: 10.1002/(SICI)1097-0215(19960315)65:6<740::AID-IJC5>3.0.CO;2-Z. View

5.
Kammerer R, Hahn S, Singer B, Luo J, von Kleist S . Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation. Eur J Immunol. 1998; 28(11):3664-74. DOI: 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D. View